Literature DB >> 10987857

Structural implications on the interaction of scorpion alpha-like toxins with the sodium channel receptor site inferred from toxin iodination and pH-dependent binding.

N Gilles1, I Krimm, F Bouet, O Froy, M Gurevitz, J M Lancelin, D Gordon.   

Abstract

The alpha-like toxin from the venom of the scorpion Leiurus quinquestriatus hebraeus (Lqh III) binds with high affinity to receptor site 3 on insect sodium channels but does not bind to rat brain synaptosomes. The binding affinity of Lqh III to cockroach neuronal membranes was fivefold higher at pH 6.5 than at pH 7.5. This correlated with an increase in the electropositive charge on the toxin surface resulting from protonation of its four histidines. Radioiodination of Tyr(14) of Lqh III abolished its binding to locust but not cockroach sodium channels, whereas the noniodinated toxin bound equally well to both neuronal preparations. Radioiodination of Tyr(10) or Tyr(21) of the structurally similar alpha-toxin from L. quinquestriatus hebraeus (LqhalphaIT), as well as their substitution by phenylalanine, had only minor effects on binding to cockroach neuronal membranes. However, substitution of Tyr(21), but not Tyr(14), by leucine decreased the binding affinity of LqhalphaIT approximately 87-fold. Thus, Tyr(14) is involved in the bioactivity of Lqh III to locust receptor site 3 and is not crucial for the binding of LqhalphaIT to this site. In turn, the aromatic ring of Tyr(21) takes part in the bioactivity of LqhalphaIT to insects. These results highlight subtle architectural variations between locust and cockroach receptor site 3, in addition to previous results demonstrating the competence of Lqh III to differentiate between insect and mammalian sodium channel subtypes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10987857     DOI: 10.1046/j.1471-4159.2000.0751735.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  Partial agonist and antagonist activities of a mutant scorpion beta-toxin on sodium channels.

Authors:  Izhar Karbat; Nitza Ilan; Joel Z Zhang; Lior Cohen; Roy Kahn; Morris Benveniste; Todd Scheuer; William A Catterall; Dalia Gordon; Michael Gurevitz
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

Review 2.  Voltage-gated sodium channel modulation by scorpion alpha-toxins.

Authors:  Frank Bosmans; Jan Tytgat
Journal:  Toxicon       Date:  2006-09-28       Impact factor: 3.033

3.  Miniaturization of scorpion beta-toxins uncovers a putative ancestral surface of interaction with voltage-gated sodium channels.

Authors:  Lior Cohen; Noa Lipstein; Izhar Karbat; Nitza Ilan; Nicolas Gilles; Roy Kahn; Dalia Gordon; Michael Gurevitz
Journal:  J Biol Chem       Date:  2008-03-13       Impact factor: 5.157

4.  Molecular analysis of the sea anemone toxin Av3 reveals selectivity to insects and demonstrates the heterogeneity of receptor site-3 on voltage-gated Na+ channels.

Authors:  Yehu Moran; Roy Kahn; Lior Cohen; Maya Gur; Izhar Karbat; Dalia Gordon; Michael Gurevitz
Journal:  Biochem J       Date:  2007-08-15       Impact factor: 3.857

5.  Synthesis, solution structure, and phylum selectivity of a spider delta-toxin that slows inactivation of specific voltage-gated sodium channel subtypes.

Authors:  Nahoko Yamaji; Michelle J Little; Hideki Nishio; Bert Billen; Elba Villegas; Yuji Nishiuchi; Jan Tytgat; Graham M Nicholson; Gerardo Corzo
Journal:  J Biol Chem       Date:  2009-07-10       Impact factor: 5.157

Review 6.  The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.

Authors:  Adi Lahiani; Ephraim Yavin; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2017-03-16       Impact factor: 4.546

7.  Comparison of a 3D-model of the classical alpha-scorpion toxin V from Leiurus quinquestriatus quinquestriatus with other scorpion toxins.

Authors:  Stefanie Bendels; Hans-Dieter Höltje
Journal:  J Comput Aided Mol Des       Date:  2004-02       Impact factor: 3.686

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.